API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
75
PharmaCompass offers a list of Fexofenadine Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Fexofenadine Hydrochloride manufacturer or Fexofenadine Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Fexofenadine Hydrochloride manufacturer or Fexofenadine Hydrochloride supplier.
PharmaCompass also assists you with knowing the Fexofenadine Hydrochloride API Price utilized in the formulation of products. Fexofenadine Hydrochloride API Price is not always fixed or binding as the Fexofenadine Hydrochloride Price is obtained through a variety of data sources. The Fexofenadine Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Fexofenadine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Fexofenadine, including repackagers and relabelers. The FDA regulates Fexofenadine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Fexofenadine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Fexofenadine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Fexofenadine supplier is an individual or a company that provides Fexofenadine active pharmaceutical ingredient (API) or Fexofenadine finished formulations upon request. The Fexofenadine suppliers may include Fexofenadine API manufacturers, exporters, distributors and traders.
click here to find a list of Fexofenadine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Fexofenadine DMF (Drug Master File) is a document detailing the whole manufacturing process of Fexofenadine active pharmaceutical ingredient (API) in detail. Different forms of Fexofenadine DMFs exist exist since differing nations have different regulations, such as Fexofenadine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Fexofenadine DMF submitted to regulatory agencies in the US is known as a USDMF. Fexofenadine USDMF includes data on Fexofenadine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Fexofenadine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Fexofenadine suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Fexofenadine Drug Master File in Japan (Fexofenadine JDMF) empowers Fexofenadine API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Fexofenadine JDMF during the approval evaluation for pharmaceutical products. At the time of Fexofenadine JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Fexofenadine suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Fexofenadine Drug Master File in Korea (Fexofenadine KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Fexofenadine. The MFDS reviews the Fexofenadine KDMF as part of the drug registration process and uses the information provided in the Fexofenadine KDMF to evaluate the safety and efficacy of the drug.
After submitting a Fexofenadine KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Fexofenadine API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Fexofenadine suppliers with KDMF on PharmaCompass.
A Fexofenadine CEP of the European Pharmacopoeia monograph is often referred to as a Fexofenadine Certificate of Suitability (COS). The purpose of a Fexofenadine CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Fexofenadine EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Fexofenadine to their clients by showing that a Fexofenadine CEP has been issued for it. The manufacturer submits a Fexofenadine CEP (COS) as part of the market authorization procedure, and it takes on the role of a Fexofenadine CEP holder for the record. Additionally, the data presented in the Fexofenadine CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Fexofenadine DMF.
A Fexofenadine CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Fexofenadine CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Fexofenadine suppliers with CEP (COS) on PharmaCompass.
A Fexofenadine written confirmation (Fexofenadine WC) is an official document issued by a regulatory agency to a Fexofenadine manufacturer, verifying that the manufacturing facility of a Fexofenadine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Fexofenadine APIs or Fexofenadine finished pharmaceutical products to another nation, regulatory agencies frequently require a Fexofenadine WC (written confirmation) as part of the regulatory process.
click here to find a list of Fexofenadine suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Fexofenadine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Fexofenadine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Fexofenadine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Fexofenadine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Fexofenadine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Fexofenadine suppliers with NDC on PharmaCompass.
Fexofenadine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Fexofenadine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Fexofenadine GMP manufacturer or Fexofenadine GMP API supplier for your needs.
A Fexofenadine CoA (Certificate of Analysis) is a formal document that attests to Fexofenadine's compliance with Fexofenadine specifications and serves as a tool for batch-level quality control.
Fexofenadine CoA mostly includes findings from lab analyses of a specific batch. For each Fexofenadine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Fexofenadine may be tested according to a variety of international standards, such as European Pharmacopoeia (Fexofenadine EP), Fexofenadine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Fexofenadine USP).